🇺🇸 Icodextrin Peritoneal Dialysis Solution in United States
122 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 122
Most-reported reactions
- Death — 94 reports (77.05%)
- Infection — 7 reports (5.74%)
- Cardiac Disorder — 4 reports (3.28%)
- Malaise — 4 reports (3.28%)
- Myocardial Infarction — 3 reports (2.46%)
- Blood Glucose Decreased — 2 reports (1.64%)
- Cerebrovascular Accident — 2 reports (1.64%)
- Dehydration — 2 reports (1.64%)
- Fungal Peritonitis — 2 reports (1.64%)
- Lung Infection — 2 reports (1.64%)
Frequently asked questions
Is Icodextrin Peritoneal Dialysis Solution approved in United States?
Icodextrin Peritoneal Dialysis Solution does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Icodextrin Peritoneal Dialysis Solution in United States?
RenJi Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.